15Nov 2019

THE EFFECTIVENESS OF LOCAL ATORVASTATIN IN THE TREATMENT OF MODERATE PERIODONTITIS

  • (B.D.S), Faculty of Dentistry, Mansoura University.
  • Lecturer of pharmaceutics, Faculty of Pharmacy – Mansoura University.
  • Asst. Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University.
  • Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Chronic periodontitis is an infectious disease resulting in inflammation within the supporting structures of teeth, loss of attachment and bone resorption. Atorvastatin is a potent synthetic competitive inhibitor of Hydroxy Methyl Glutaryl-Co enzyme A reductase. It has a favourable effect on bone, as well as immunomodulatory effect. Aim: The aim of this study was to determine the effectiveness of local Atorvastatin as an adjunct to scaling and root planning in the treatment of chronic periodontitis. Subjects and method: Fivteen chronic periodontits patients were involved in this study. Split mouth design was utilized. Clinical parameters (Gingival Index, Plaque Index, Bleeding On Probing, Clinical Attachment Loss, probing Pocket Depth) were recorded at baseline and after eight weeks after treatment. Gingival crevicular fluid samples were collected at baseline and eight weeks after treatment from both test and control sites, and osteocalcin level was assessed. All patients received scaling and root planning, the test sites only were locally injected with atorvastatin gel. Results: Clinical parameters of test sites showed very highly significant reduction in at p<0.001 versus control sites eight weeks after treatment. Test sites only showed significant reduction in osteocalcin level in gingival crevicular fluid at p=0.005 versus control sites, eight weeks after treatment. Conclusion: Locally applicated Atorvastain adjunctive with scaling and root planning could be effective in treatment of chronic periodontitis.

  1. Pejčić A, Obradović R, Kesić L, Kojović D. Smoking and periodontal disease: a review. Med Biol. 2007;14(2):53?9.
  2. Kamma JJ, Slots J. Herpesviral?bacterial interactions in aggressive periodontitis. J Clin Periodontol. 2003;30(5):420?426.
  3. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134?144.
  4. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ. Communication among oral bacteria. Microbiol Mol Biol Rev. 2002;66(3):486?505.
  5. Sanz I, Alonso B, Carasol M, Herrera D, Sanz M. Nonsurgical treatment of periodontitis. J Evid Based Dent Pract. 2012;12(3):76?86.
  6. Dentino A, Lee S, Mailhot J, Hefti AF. Principles of periodontology. Periodontol 2000. 2013;61(1):16?53.
  7. Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm. 2000;50(1):83?99.
  8. Garg S. Local Drug Delivery Systems as an Adjunct to Cure Periodontitis-The Novel Dental Applicant. Pharm Methods. 2015;6(1):1.
  9. Pattanshetti JI, Tiwari I, Singh G, Tazyeen F, Parihar AS, Khare N. Local Drug Delivery Modalities in Treatment of Periodontitis: A Review. J Int Oral Health. 2016;8(2):296.
  10. Gazzerro P, Proto MC, Gangemi G, Malfitano AM, Ciaglia E, Pisanti S, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev. 2012;64(1):102?146.
  11. Landmesser U, Bahlmann F, Mueller M, Spiekermann S, Kirchhoff N, Schulz S, et al. Simvastatin versus ezetimibe pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation. 2005;111(18):2356?2363.
  12. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem. 2004;92(3):458?471.
  13. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone. 2007;40(6):1581?1587.
  14. Henwood JM, Heel RC. Lovastatin. Drugs. 1988;36(4):429?454.
  15. Kishida Y, Naito A, Iwado S, Terahara A, Tsujita Y. Research and development of pravastatin. Yakugaku Zasshi. 1991;111(9):469?487.
  16. Todd PA, Goa KL. Simvastatin. Drugs. 1990;40(4):583?607.
  17. Mart?n-Ventura JL, Blanco-Colio LM, G?mez-Hern?ndez A, Mu?oz-Garc?a B, Vega M, Serrano J, et al. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke. 2005;36(8):1796?1800.
  18. Li J, Li J-J, He J-G, Nan J, Guo Y, Xiong C. Atorvastatin Decreases C-Reactive Protein-Induced Inflammatory Response in Pulmonary Artery Smooth Muscle Cells by Inhibiting Nuclear Factor-κB Pathway. Cardiovasc Ther. 2010;28(1):8?14.
  19. Sousa LH, Linhares EV, Alexandre JT, Lisboa MR, Furlaneto F, Freitas R, et al. Effects of Atorvastatin on Periodontitis of Rats Subjected to Glucocorticoid-induced Osteoporosis. J Periodontol. 2016;(00):1?17.
  20. de Ara?jo J?nior RF, Souza TO, de Moura LM, Torres KP, de Souza LB, Alves M do SCF, et al. Atorvastatin decreases bone loss, inflammation and oxidative stress in experimental periodontitis. PloS One. 2013;8(10):e75322.
  21. Dalcico R, de Menezes AM, Deocleciano OB, Ori? RB, Vale ML, Ribeiro RA, et al. Protective mechanisms of simvastatin in experimental periodontal disease. J Periodontol. 2013;84(8):1145?1157.
  22. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286(5446):1946?1949.
  23. Viereck V, Gr?ndker C, Blaschke S, Frosch K-H, Schoppet M, Emons G, et al. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts. J Cell Biochem. 2005;96(6):1244?1253.
  24. Chang B, Yang J, Li H, Lu S, Chen L, Fang P. Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats. Pharm- Int J Pharm Sci. 2011;66(7):535?537.
  25. AlRowis R, AlMoharib HS, AlMubarak A, Bhaskardoss J, Preethanath RS, Anil S. Oral fluid-based biomarkers in periodontal disease?Part 2. Gingival crevicular fluid. J Int Oral Health JIOH. 2014;6(5):126.
  26. Kinney JS, Ramseier CA, Giannobile WV. Oral Fluid-Based Biomarkers of Alveolar Bone Loss in Periodontitis. Ann N Y Acad Sci. 2007 Mar 1;1098(1):230?51.
  27. Neve A, Corrado A, Cantatore FP. Osteocalcin: Skeletal and extra-skeletal effects. J Cell Physiol. 2013;228(6):1149?1153.
  28. Lee AJ, Walsh TF, Hodges SJ, Rawlinson A. Gingival crevicular fluid osteocalcin in adult periodontitis. J Clin Periodontol. 1999;26(4):252?256.
  29. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000;289(5484):1501?1504.
  30. Bullon P, Goberna B, Guerrero JM, Segura JJ, Perez-Cano R, Martinez-Sahuquillo A. Serum, saliva, and gingival crevicular fluid osteocalcin: their relation to periodontal status and bone mineral density in postmenopausal women. J Periodontol. 2005;76(4):513?519.
  31. Bullon P, Chandler L, Segura Egea JJ, Perez Cano R, Martinez Sahuquillo A. Osteocalcin in serum, saliva and gingival crevicular fluid: their relation with periodontal treatment outcome in postmenopausal women. Med Oral Patol Oral Cir Bucal Internet. 2007;12(3):193?197.
  32. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1?6.
  33. Kunimatsu K, Mataki S, Tanaka H, Mine N, Kiyoki M, Hosoda K, et al. A cross-sectional study on osteocalcin levels in gingival crevicular fluid from periodontal patients. J Periodontol. 1993;64(9):865?869.
  34. Thylin MR, McConnell JC, Schmid MJ, Reckling RR, Ojha J, Bhattacharyya I, et al. Effects of simvastatin gels on murine calvarial bone. J Periodontol. 2002;73(10):1141?1148.
  35. Martande SS, Kumari M, Pradeep AR, Singh SP, Suke DK. Comparative evaluation of efficacy of subgingivally delivered 1.2% Atorvastatin and 1.2% Simvastatin in the treatment of intrabony defects in chronic periodontitis: a randomized controlled trial. J Dent Res Dent Clin Dent Prospects. 2017;11(1):18.
  36. Mlachkova AM, Popova CL. Dental Investigations: Efficiency of Nonsurgical Periodontal Therapy in Moderate Chronic Periodontitis. Folia Med (Plovdiv). 2014;56(2):109?115.
  37. Garg T, Bilandi A, Kapoor B, Kumar S, Joshi R. Scaffold: Tissue engineering and regenerative medicine. Int Res J Pharm. 2011;2(12):37?42.
  38. Zhang Y, Bradley AD, Wang D, Reinhardt RA. Statins, bone metabolism and treatment of bone catabolic diseases. Pharmacol Res. 2014;88:53?61.
  39. Taba Jr M, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am. 2005;49(3):551.
  40. Ram VS, Parthiban US, Mithradas N, Prabhakar R. Bonebiomarkers in periodontal disease: a review article. J Clin Diagn Res JCDR. 2015;9(1):ZE07.
  41. Daily ZA, Mohammed AN. Periodontal Health Status and Assessment of Osteocalcin levels in Saliva of Diabetic Patients and Systemically Healthy Persons (Comparative study). J Baghdad Coll Dent. 2017;29(1):89?95.
  42. Mascarenhas P, Gapski R, Al-Shammari K, Wang H-L. Influence of sex hormones on the periodontium. J Clin Periodontol. 2003;30(8):671?681.
  43. Lieff S, Boggess KA, Murtha AP, Jared H, Madianos PN, Moss K, et al. The oral conditions and pregnancy study: periodontal status of a cohort of pregnant women. J Periodontol. 2004;75(1):116?126.
  44. Zambon JJ, Grossi SG, Machtei EE, Ho AW, Dunford R, Genco RJ. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol. 1996;67:1050?1054.
  45. Makino A, Yamada S, Okuda K, Kato T. Nicotine involved in periodontal disease through influence on cytokine levels. FEMS Immunol Med Microbiol. 2008;52(2):282?286.
  46. Slots J?, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000. 2002;28(1):106?176.
  47. Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol. 1981;52(8):410?415.
  48. McMullen JA, Dyke TV, Horoszewicz HU, Genco RJ. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol. 1981;52(4):167?173.
  49. Pandis N, Walsh T, Polychronopoulou A, Katsaros C, Eliades T. Split-mouth designs in orthodontics: an overview with applications to orthodontic clinical trials. Eur J Orthod. 2013;35(6):783?789.
  50. Carvalho LH, D??vila GB, Leao A, Haffajee AD, Socransky SS, Feres M. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. J Clin Periodontol. 2004;31(12):1070?1076.
  51. Colombo APV, Teles RP, Torres MC, Rosal?m Jr W, Mendes MCS, Souto RM, et al. Effects of non-surgical mechanical therapy on the subgingival microbiota of Brazilians with untreated chronic periodontitis: 9-month results. J Periodontol. 2005;76(5):778?784.
  52. Ambr?sio LMB, Rovai ES, Sendyk DI, Holzhausen M, Pannuti CM. Does the adjunctive use of statins provide additional benefits to nonsurgical periodontal treatment? A systematic review and meta-analysis. J Periodontal Res. 2017;
  53. Shah M, Muley P, Muley A. Are statins worthy for treatment of periodontitis? A systematic review and meta-analysis. Adv Hum Biol. 2017;7(1):8.
  54. Bertl KB Bj?orn KliKristina, Arlinda Parllaku, Nikolaos Pandis,, K?are Buhlin. The effect of local and systemic statin use as an adjunct to non-surgical and surgical periodontal therapy?A systematic review and meta-analysis. J Dent.
  55. Pradeep AR, Kumari M, Rao NS, Martande SS, Naik SB. Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: A randomized controlled clinical trial. J Periodontol. 2013;84(7):871?879.
  56. Sinjab K, Zimmo N, Lin G-H, Chung M-P, Shaikh L, Wang H-L. The Effect of Locally Delivered Statins on Treating Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis. J Periodontol. 2017;88(4):357?367.
  57. Rosenberg DR, Andrade CX, Chaparro AP, Inostroza CM, Ramirez V, Mestres J, et al. Short-term effects of 2% atorvastatin dentifrice as an adjunct to periodontal therapy: a randomized double-blind clinical trial. J Clin Periodontol. 2015;42:3.
  58. Fajardo ME, Rocha ML, S?nchez-Marin FJ, Espinosa-Ch?vez EJ. Effect of atorvastatin on chronic periodontitis: a randomized pilot study. J Clin Periodontol. 2010;37(11):1016?1022.
  59. Pradeep AR, Rao NS, Bajaj P, Kumari M. Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial. J Periodontol. 2013;84(1):24?31.
  60. Saxlin T, Suominen-Taipale L, Knuuttila M, Alha P, Yl?stalo P. Dual effect of statin medication on the periodontium. J Clin Periodontol. 2009;36(12):997?1003.
  61. Marin LM. Efectos pleitr?picos de los f?rmacos hipolipemiantes. Cardiovasc RISK FACTORS. 2001;10(3):145?155.
  62. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89.
  63. Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res. 2006;85(6):520?523.
  64. Fentoğlu ?, Kırzıoğlu FY, ?zdem M, Kocak H, S?t?? R, Sert T. Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment. Oral Dis. 2012;18(3):299?306.
  65. Suresh S, Narayana S, Jayakumar P, Sudhakar U, Pramod V, others. Evaluation of anti-inflammatory effect of statins in chronic periodontitis. Indian J Pharmacol. 2013;45(4):391.
  66. Estanislau IMG, Terceiro IRC, Lisboa MRP, Teles P de B, Carvalho R de S, Martins RS, et al. Pleiotropic effects of statins on the treatment of chronic periodontitis?a systematic review. Br J Clin Pharmacol. 2015;79(6):877?885.
  67. Nakashima K, Roehrich N, Cimasoni G. Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol. 1994;21(5):327?333.
  68. Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP, Williams RC. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. J Clin Periodontol. 1995;22(12):903?910.
  69. Baumgrass R, Williamson MK, Price PA. Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S. J Bone Miner Res. 1997;12(3):447?455.
  70. Eley BM, Cox SW. Cathepsin B/L-, elastase-, tryptase-, trypsin-and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: correlation with clinical parameters in untreated chronic periodontitis patients. J Periodontal Res. 1992;27(1):62?69.
  71. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev. 1989;69(3):990?1047.
  72. Villaf?n-Bernal JR, S?NcHEz-ENR?qUEz S, Mu?oz-Valle JF. Molecular modulation of osteocalcin and its relevance in diabetes. Int J Mol Med. 2011;28(3):283?293.
  73. Mundy GR, Poser JW. Chemotactic activity of theγ-carboxyglutamic acid containing protein in bone. Calcif Tissue Int. 1983;35(1):164?168.
  74. Glowacki J, Lian JB. Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differ. 1987;21(4):247?254.
  75. Liu S, Bertl K, Sun H, Liu Z-H, Andrukhov O, Rausch-Fan X. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. Hum Cell. 2012;25(2):29?35.
  76. Mennickent S, Bravo M, Calvo C, Avello M. Efectos pleiotr?picos de las estatinas. Rev M?dica Chile. 2008;136(6):775?782.
  77. Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci. 1999;96(1):133?138.
 

[Mayada M. Khoder, Germeen N.S. Girgis, Mohamed M. Anees and Jilan M. Youssef (2019); THE EFFECTIVENESS OF LOCAL ATORVASTATIN IN THE TREATMENT OF MODERATE PERIODONTITIS Int. J. of Adv. Res. 7 (Nov). 818-825] (ISSN 2320-5407). www.journalijar.com

mayada khodeir

DOI:

Article DOI: 10.21474/IJAR01/10080      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10080

Download Full Paper

Download PDF No. of Downloads: 27 | No. of Views: 82